维生素E摄入量与甲状腺功能障碍及自身免疫性甲状腺炎患病率:NHANES数据的横断面分析
基于NHANES 2007至2012年数据,纳入7,773名无甲状腺疾病的非妊娠成人,按膳食维生素E摄入量三分位分组。结果显示高摄入组(T3)与亚临床甲状腺功能减退症(SCH)患病率较低相关(OR=0.28,CI=0.15-0.54,p<0.001),男性中亚组保护效应更明显,但女性中无显著关联。
要点
- SCH患病率随维生素E摄入增加呈下降趋势:T1组3.63%、T2组3.07%、T3组1.85%(P-trend=0.013)。
- 一般人群中,T3组维生素E摄入与SCH患病率较低显著相关(OR=0.28,CI=0.15-0.54,p<0.001)。
- 男性中,T2和T3组维生素E摄入均与SCH和自身免疫性甲状腺炎患病率较低相关,女性中无显著关联。
核心结论
- 研究结果表明,较高的维生素E摄入与男性中亚临床甲状腺功能减退症和自身免疫性甲状腺炎的较低患病率相关。
研究设计与样本
- 研究为横断面分析,使用美国国家健康与营养调查(NHANES)2007至2012年数据,共纳入7,773名无甲状腺疾病的非妊娠成人,按膳食维生素E摄入量三分位分组:T1组≤4.53 mg、T2组4.54-8.10 mg、T3组≥8.11 mg。
- 采用复杂多阶段概率抽样设计,使用R软件进行分析。
主要发现
- 亚临床甲状腺功能减退症(SCH)患病率在T1、T2、T3组分别为3.63%、3.07%、1.85%,呈下降趋势(P-trend=0.013)。
- 一般人群中,高维生素E摄入(T3)与SCH患病率较低显著相关(OR=0.28,CI=0.15-0.54,p<0.001)。
- 男性亚组中,中等(T2,OR=0.45,CI=0.23-0.87,p=0.020)和高(T3,OR=0.19,CI=0.09-0.39,p<0.001)膳食维生素E摄入均与SCH患病率较低相关。
- 男性中,中等(T2,OR=0.59,CI=0.37-0.93,p=0.024)和高(T3,OR=0.52,CI=0.36-0.75,p<0.001)膳食维生素E摄入与自身免疫性甲状腺炎(AIT)患病率较低相关。
- 女性中未观察到显著关联。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background: Thyroid disorders are associated with various dietary factors and nutritional elements. The aim of this study was to investigate the relationships between dietary vitamin E intake and the prevalence of thyroid dysfunction and thyroid antibody positivity using data from the National Health and Nutrition Examination Survey (NHANES) database. Methods: Data from the NHANES database collected between 2007 and 2012 were analyzed. A total of 7,773 nonpregnant adults without preexisting thyroid diseases and possessing complete thyroid and vitamin E data were included in the study. The participants were categorized into tertiles based on their dietary vitamin E intake: the lowest group (T1: ≤4.53 mg), the intermediate group (T2: 4.54-8.10 mg), and the highest group (T3: ≥8.11 mg). We used a complex multistage probability sampling design in conjunction with R software. We compared thyroid indices, the prevalence of overt and subclinical hyperthyroidism or hypothyroidism, and the occurrence of thyroid antibody positivity among the three groups based on vitamin E intake. Weighted multinomial logistic regression was used to assess the association between dietary vitamin E intake and thyroid disorders. Restricted cubic splines (RCSs) were used to explore potential nonlinear associations. Results: The prevalence rates of subclinical hypothyroidism (SCH) were 3.63%, 3.07%, and 1.85% in T1, T2, and T3, respectively, indicating a decreasing trend (P-trend = 0.013). In the general population, high vitamin E intake (T3) was significantly associated with a lower prevalence of SCH (OR = 0.28, CI = 0.15-0.54, p < 0.001). Subgroup analysis revealed a more pronounced protective effect in males, with both moderate (T2, OR = 0.45, CI = 0.23-0.87, p = 0.020) and high (T3, OR = 0.19, CI = 0.09-0.39, p < 0.001) dietary vitamin E intake being associated with a lower prevalence of SCH. In addition, moderate (T2, OR = 0.59, CI = 0.37-0.93, p = 0.024) and high (T3, OR = 0.52, CI = 0.36-0.75, p < 0.001) dietary vitamin E intake was associated with a lower prevalence of autoimmune thyroiditis (AIT) in males. However, no significant association was observed among females. Conclusion: The findings of this study suggest that a higher intake of vitamin E is associated with lower prevalence rates of SCH and autoimmune thyroiditis among males.
引用
- Liu S, Lu C, He L, et al. Vitamin E Intake and Prevalence Rates of Thyroid Dysfunction and Autoimmune Thyroiditis: A Cross-Sectional Analysis of NHANES Data. Thyroid. 2024. PMID: 38534308. doi:10.1089/thy.2023.0561
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。